Tharimmune Stock Price on November 15, 2024
THAR Stock | 2.08 0.18 7.96% |
If you're considering investing in Tharimmune Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tharimmune stands at 2.08, as last reported on the 1st of December, with the highest price reaching 2.26 and the lowest price hitting 2.02 during the day. Tharimmune owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0046, which indicates the firm had a -0.0046% return per unit of risk over the last 3 months. Tharimmune exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tharimmune's Variance of 111.17, risk adjusted performance of 0.0038, and Coefficient Of Variation of (13,877) to confirm the risk estimate we provide.
At this time, Tharimmune's Total Stockholder Equity is relatively stable compared to the past year. As of 12/01/2024, Liabilities And Stockholders Equity is likely to grow to about 11.5 M, while Capital Stock is likely to drop 931.70. . At this time, Tharimmune's Price Book Value Ratio is relatively stable compared to the past year. As of 12/01/2024, Price To Book Ratio is likely to grow to 0.08, while Price Earnings To Growth Ratio is likely to drop 0. Tharimmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Tharimmune |
Sharpe Ratio = -0.0046
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | THAR |
Estimated Market Risk
10.68 actual daily | 95 95% of assets are less volatile |
Expected Return
-0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tharimmune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tharimmune by adding Tharimmune to a well-diversified portfolio.
Price Book 1.0243 | Book Value 2.35 | Enterprise Value 81.7 K | Enterprise Value Ebitda (6.32) | Shares Float 1.5 M |
Related Headline
Supercom Headline on 15th of November 2024
SuperCom Lowered to Sell Rating by StockNews.com by thelincolnianonline.com
StockNews.com cut shares of SuperCom from a hold rating to a sell rating in a report published on Tuesday morning. SuperCom Price Performance NASDAQSPCB opened at 3.60 on Tuesday. SuperCom has a one year low of 2.55 and a one year high of 10.90. The company has a market cap of
Tharimmune Valuation on November 15, 2024
It is possible to determine the worth of Tharimmune on a given historical date. On November 15, 2024 Tharimmune was worth 2.14 at the beginning of the trading date compared to the closed value of 2.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tharimmune stock. Still, in general, we apply an absolute valuation method to find Tharimmune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tharimmune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tharimmune's related companies.
Open | High | Low | Close | Volume | |
2.25 | 2.29 | 2.10 | 2.23 | 169,015 | |
11/15/2024 | 2.14 | 2.31 | 2.12 | 2.17 | 68,539 |
2.31 | 2.42 | 1.85 | 2.37 | 8,770,953 |
Backtest Tharimmune | | | Tharimmune History | | | Tharimmune Valuation | Previous | Next |
Tharimmune Trading Date Momentum on November 15, 2024
On November 18 2024 Tharimmune was traded for 2.37 at the closing time. The top price for the day was 2.42 and the lowest listed price was 1.85 . The trading volume for the day was 8.8 M. The trading history from November 18, 2024 was a factor to the next trading day price gain. The trading price change against the next closing price was 9.22% . The trading price change against the current closing price is 18.43% . |
Tharimmune Fundamentals Correlations and Trends
By evaluating Tharimmune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tharimmune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tharimmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tharimmune Stock history
Tharimmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tharimmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tharimmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tharimmune stock prices may prove useful in developing a viable investing in Tharimmune
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 87 K | 44.5 K | |
Net Loss | -7.6 M | -7.2 M |
Tharimmune Quarterly Net Working Capital |
|
Tharimmune Stock Technical Analysis
Tharimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tharimmune Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Tharimmune cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tharimmune December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Tharimmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tharimmune shares will generate the highest return on investment. By undertsting and applying Tharimmune stock market strength indicators, traders can identify Tharimmune entry and exit signals to maximize returns
Tharimmune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tharimmune's price direction in advance. Along with the technical and fundamental analysis of Tharimmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tharimmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0038 | |||
Jensen Alpha | (0.13) | |||
Total Risk Alpha | (1.85) | |||
Treynor Ratio | (0.23) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.